PANDA Gym: Automated Assessment of Neurodevelopment in Infants at Risk for Motor Disability

January 30, 2024 updated by: University of Pennsylvania

Automated Assessment of Neurodevelopment in Infants at Risk for Motor Disability

Early childhood detection of motor delays or impairments provides the opportunity for early treatment which improves health outcomes. This study will use state of the art sensors combined with machine learning algorithms to develop objective, accurate, easy-to-use tools for the early scoring of deficits and lays the foundation for the early prediction of physical disability.

Study Overview

Detailed Description

For children with neurodevelopmental disabilities, early treatment in the first year of life improves long-term outcomes. However, the investigators are currently held back by inadequacies of available clinical tests to measure and predict impairment. Existing tests are hard to administer, require specialized training, and have limited long-term predictive value. There is a critical need to develop an objective, accurate, easy-to-use tool for the early prediction of long-term physical disability. The field of pediatrics and infant development would greatly benefit from a quantitative score that would correlate with existing clinical measures used today to detect movement impairments in very young infants. To realize a new generation of tests that will be easy to administer, the investigators will obtain large datasets of infants playing in an instrumented gym or simply being recorded while moving in a supine posture. Video and sensor data analyses will convert movement into feature vectors based on our knowledge of the problem domain. Our approach will use machine learning to relate these feature vectors to currently recommended clinical tests or other ground truth information. The power of this design is that algorithms can utilize many aspects of movement to produce the relevant scores.

Study Type

Observational

Enrollment (Estimated)

1700

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

    • Pennsylvania
      • Philadelphia, Pennsylvania, United States, 19104
        • Recruiting
        • Childrens Hospital Of Philadelphia
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

1 second to 6 months (Child)

Accepts Healthy Volunteers

Yes

Sampling Method

Non-Probability Sample

Study Population

Study 1: 150 infants (75 with early brain injury, 75 Control). Age 1-6 months. Study 2: 50 infants (25 with early brain injury, 25 Control). Age 1 month. Study 3: 1200 infants (400 with EBI, 400 preterm without EBI/risk for future disability, 400 controls) from video data. Age 1-6 months.

Infants without EBI/risk for future disability: Infants without known brain injuries, but with a history of preterm birth less than 32 week gestation, significant medical problems, difficulty eating, or who lack head control at 4 months of age or later will be classified as moderate risk.

Description

Infants, male and female, between 0-6 months (Infants older than 6 months before initial enrollment will be excluded).

  • Infants with early brain injury (EBI):

    • Hydrocephalus
    • Hypoxic-ischemic encephalopathy (HIE)
    • Periventricular leukomalacia (PVL)
    • Intraventricular hemorrhage (IVH)
    • Stroke
  • Healthy infants (controls):

    o No history of early brain injury (EBI)

  • Infants without EBI/risk for future disability:

    • Infants without known brain injuries, but with a history of preterm birth less than 32-week gestation with significant medical problems, difficulty eating, or who lack head control at 4 months of age or later will be classified as moderate risk.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Other
  • Time Perspectives: Prospective

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Cross-sectional-150 infants (atypical vs typical)
Arm (Study)1: To assess the concurrent validity of a multimodal instrumented gym with existing clinical tools. Here, using 150 infants, we will focus on converting data from an instrumented gym into estimates of the standard clinical tests.
Infants will lie supine on a flat surface and will be placed in the PANDA gym where they either move by themselves or will interact with an instrumented toy. We will collect video, mat, and toy data from PANDA gym under two conditions: 1) infants playing supine without a toy and 2) infants reach, grasp and kick of the new PANDA toy. A test session will proceed as follows: The infant will be placed on his or her back at a predetermined position on the gym mat for the 2-minute no toy condition. Next, the toy will be given to the baby and adjusted for the infant to reach or kick. A caregiver will be seated at the head of the baby (out of a baby's sight) to provide comfort if needed. Testing will be done in NICU or at daycare or the rehabilitation robotics lab at University of Pennsylvania.
Longitudinal cohort - 50 infants (atypical vs typical)
Arm (Study) 2: To discover the features related to long-term motor development. Here we will convert data collected longitudinally from 50 infants, using both instrumented gym and video recordings, into estimates standard clinical tests change over time and track features over developmental timescales.
Infants will lie supine on a flat surface and will be placed in the PANDA gym where they either move by themselves or will interact with an instrumented toy. We will collect video, mat, and toy data from PANDA gym under two conditions: 1) infants playing supine without a toy and 2) infants reach, grasp and kick of the new PANDA toy. A test session will proceed as follows: The infant will be placed on his or her back at a predetermined position on the gym mat for the 2-minute no toy condition. Next, the toy will be given to the baby and adjusted for the infant to reach or kick. A caregiver will be seated at the head of the baby (out of a baby's sight) to provide comfort if needed. Testing will be done in NICU or at daycare or the rehabilitation robotics lab at University of Pennsylvania.
Cross-sectional-1500 infants (atypical vs typical)
Arm (Study) 3: To develop a computer vision-based algorithm to quantify infant motor performance from a single-camera video. Here using video data from 1200 infants, plus those gathered from Arm 1 and Arm 2, we will extract pose data from single-camera video recordings and convert these into kinematic features and relevant scores needed to classify infant movement.

The parent or legal guardian will be consented first via the virtual rounding mobile app. They will also be asked to fill out general surveys including, a demographic survey, and a case report form, and a user feedback survey that provides relevant information, on both the family's and infant's medical history and experience. (see the flow-chart for the app). Within the caregiver survey, we will request the pediatrician (or primary care physician) name. We believe that with the baby name, caregiver name, zip code, and physician name, we will be able to locate the physician if needed.

Parents or legal guardians or the research will be asked to collect video via the MOBILE app. They will be instructed to ensure that the infant lies supine in no more than one-layer of tight-fitting clothing (i.e. infant onesie) while calm and awake. In all cases, we will have video recordings of the baby. They will be asked to upload the video to the app.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Prechtl's General Movements Assessment (GMA) score
Time Frame: 1 months
The spontaneous movements of infants aged 1 to 5 months will be classified with the GMA. The GMA is a qualitative observational scale of infant movement. Normal infant movement is described as a writhing movement at earlier ages, characterized by small, circular and elegant movements, and fidgety movements at older ages.
1 months
Prechtl's General Movements Assessment (GMA) score
Time Frame: 2 months
The spontaneous movements of infants aged 1 to 5 months will be classified with the GMA. The GMA is a qualitative observational scale of infant movement. Normal infant movement is described as a writhing movement at earlier ages, characterized by small, circular and elegant movements, and fidgety movements at older ages.
2 months
Prechtl's General Movements Assessment (GMA) score
Time Frame: 3 months
The spontaneous movements of infants aged 1 to 5 months will be classified with the GMA. The GMA is a qualitative observational scale of infant movement. Normal infant movement is described as a writhing movement at earlier ages, characterized by small, circular and elegant movements, and fidgety movements at older ages.
3 months
Prechtl's General Movements Assessment (GMA) score
Time Frame: 4 months
The spontaneous movements of infants aged 1 to 5 months will be classified with the GMA. The GMA is a qualitative observational scale of infant movement. Normal infant movement is described as a writhing movement at earlier ages, characterized by small, circular and elegant movements, and fidgety movements at older ages.
4 months
Prechtl's General Movements Assessment (GMA) score
Time Frame: 5 months
The spontaneous movements of infants aged 1 to 5 months will be classified with the GMA. The GMA is a qualitative observational scale of infant movement. Normal infant movement is described as a writhing movement at earlier ages, characterized by small, circular and elegant movements, and fidgety movements at older ages.
5 months
The Test of Infant Motor Performance (TIMP) score
Time Frame: 1 month
The TIMP, a test of infant movement designed to be used at term age and up to 16 weeks after, will be used to assess infants between 0 and 4 months.
1 month
The Test of Infant Motor Performance (TIMP) score
Time Frame: 2 months
The TIMP, a test of infant movement designed to be used at term age and up to 16 weeks after, will be used to assess infants between 0 and 4 months.
2 months
The Test of Infant Motor Performance (TIMP) score
Time Frame: 3 months
The TIMP, a test of infant movement designed to be used at term age and up to 16 weeks after, will be used to assess infants between 0 and 4 months.
3 months
The Test of Infant Motor Performance (TIMP) score
Time Frame: 4 months
The TIMP, a test of infant movement designed to be used at term age and up to 16 weeks after, will be used to assess infants between 0 and 4 months.
4 months
Alberta Infant Motor Scale (AIMS) score
Time Frame: 3 months
The AIMS is a quick motor screen that will be administered with infants 3,6 months of age.
3 months
Alberta Infant Motor Scale (AIMS) score
Time Frame: 4 months
The AIMS is a quick motor screen that will be administered with infants 3,6 months of age.
4 months
Alberta Infant Motor Scale (AIMS) score
Time Frame: 5 months
The AIMS is a quick motor screen that will be administered with infants 3,6 months of age.
5 months
Alberta Infant Motor Scale (AIMS) score
Time Frame: 6 months
The AIMS is a quick motor screen that will be administered with infants 3,6 months of age.
6 months
Hammersmith Infant Neurological Examination (HINE) score
Time Frame: 1 months
The HINE, an examination of general infant neurological function and movement, will be administered with infants at all ages.
1 months
Hammersmith Infant Neurological Examination (HINE) score
Time Frame: 2 months
The HINE, an examination of general infant neurological function and movement, will be administered with infants at all ages.
2 months
Hammersmith Infant Neurological Examination (HINE) score
Time Frame: 3 months
The HINE, an examination of general infant neurological function and movement, will be administered with infants at all ages.
3 months
Hammersmith Infant Neurological Examination (HINE) score
Time Frame: 4 months
The HINE, an examination of general infant neurological function and movement, will be administered with infants at all ages.
4 months
Hammersmith Infant Neurological Examination (HINE) score
Time Frame: 5 months
The HINE, an examination of general infant neurological function and movement, will be administered with infants at all ages.
5 months
Ability to predict The Hammersmith Infant Neurological Examination (HINE) score
Time Frame: 6 months
The regression R-squared resulting from regression algorithm to predict the Test of Infant Motor Performance (TIMP)
6 months
Ability to predict The Test of Infant Motor Performance (TIMP) score
Time Frame: 6 months
The regression R-squared resulting from regression algorithm to predict the Test of Infant Motor Performance (TIMP)
6 months
Ability to predict the Alberta Infant Motor Scale (AIMS) score
Time Frame: 6 months
The regression R-squared resulting from a regression algorithm to predict the Alberta Infant Motor Scale (AIMS) score
6 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Average Path Length
Time Frame: 1 month
The average path length of the center of pressure during a 2 minute session on the mat
1 month
Average Path Length
Time Frame: 6 months
The average path length of the center of pressure during a 2 minute session on the mat
6 months
Toy contact time
Time Frame: 1 month
Average voluntary contact time with the Toy - including sum of contact time with each arm and each leg
1 month
Toy contact time
Time Frame: 6 months
Average voluntary contact time with the Toy - including sum of contact time with each arm and each leg
6 months
Toy contact frequency
Time Frame: 1 month
Average # of voluntary contacts with the Toy - mean of with each arm and each leg
1 month
Toy contact frequency
Time Frame: 6 month
Average # of voluntary contacts with the Toy - mean of with each arm and each leg
6 month

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Michelle J Johnson, PhD, The University of Pennsylvania

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

November 1, 2020

Primary Completion (Estimated)

July 1, 2025

Study Completion (Estimated)

July 1, 2025

Study Registration Dates

First Submitted

December 17, 2019

First Submitted That Met QC Criteria

March 23, 2020

First Posted (Actual)

March 25, 2020

Study Record Updates

Last Update Posted (Estimated)

February 1, 2024

Last Update Submitted That Met QC Criteria

January 30, 2024

Last Verified

January 1, 2024

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Neurodevelopmental Disorders

Clinical Trials on PANDA Gym

3
Subscribe